Huakang Biomedical Holdings Company Limited (8622.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Address
Effectual Building
Wan Chai,
Hong Kong
Phone
852 2202 8988
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
91
First IPO Date
December 13, 2018
| Name | Title | Pay | Year Born |
| Chunguang Zhang | Chief Executive Officer & Executive Director | 832,348 | 1968 |
| Xunyong Zhou | Co-Chairman | 46,306 | 1976 |
| Yujing Zhang | Co-Chairman | 46,306 | 1985 |
| Lai Yin Poon | Chief Financial Officer, Compliance Officer & Executive Director | 914,541 | 1972 |
| Lai Ki Chau | Financial Controller & Company Secretary | 0 | 1984 |
Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.